Hadassah and NeuroGenesis Announce Groundbreaking Results of Multiple Sclerosis Study
December 09, 2020
December 09, 2020
NEW YORK, Dec. 9 (TNSJou) -- Hadassah, The Women's Zionist Organization of America, issued the following news release on Dec. 8:
NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative diseases, and Hadassah Medical Organization (HMO) in Jerusalem announced today highly positive results from a placebo-controlled Phase 2 clinical trial. The trial, which was conducted by Prof. Dimitrios Karussis, lead prin . . .
NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative diseases, and Hadassah Medical Organization (HMO) in Jerusalem announced today highly positive results from a placebo-controlled Phase 2 clinical trial. The trial, which was conducted by Prof. Dimitrios Karussis, lead prin . . .